Early research (Phase 1)Ended earlyNCT00087009
What this trial is testing
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Memorial Sloan Kettering Cancer Center 3